Provoking Factors for Aggravation of Congenital Vascular Malformation

Chapter

Abstract

Congenital vascular malformations, which represent developmental abnormalities of vascular or development, may affect capillaries, veins, arteries, lymphatics, or any combination of these vascular channels. Characteristically, these lesions “grow in parallel with the growth of the patient.” However, there are certain scenarios in which the vascular malformation can be “aggravated,” generating unwanted symptoms and potential complications. Inciting factors include time, trauma, hormonal changes (puberty, the menstrual cycle, pregnancy), infection, thromboses, and surgical intervention. Unwanted associated symptoms include thromboses, bleeding, inflammation, increased size of lesions, functional impairment, tissue hypertrophy, hypertrophic nodules, pathologic fracture, and other morbidities.

Bibliography

  1. 1.
    Geronemus RG, Ashinoff R. The medical necessity of evaluation and treatment of port-wine stains. J Dermatol Surg Oncol. 1991;17(1):76–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Greene AK, Taber SF, Ball KL, Padwa BL, Mulliken JB. Sturge-Weber syndrome: soft-tissue and skeletal overgrowth. J Craniofac Surg. 2009;20(Suppl 1):617–21.CrossRefPubMedGoogle Scholar
  3. 3.
    van Drooge AM, de Rie M, van der Veen W, Wolkerstorfer A. Port-wine stain progression: is prevention by pulsed dye laser therapy possible? Eur J Dermatol. 2013;23(2):282–3.PubMedGoogle Scholar
  4. 4.
    Lee JW, Chung HY, Cerrati EW, March TM, Waner M. The natural history of soft tissue hypertrophy, bony hypertrophy, and nodule formation in patients with untreated head and neck capillary malformations. Dermatol Surg. 2015;41(11):1241–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Tark KC, Lew DH, Lee DW. The fate of long-standing port-wine stain and its surgical management. Plast Reconstr Surg. 2011;127(2):784–91.CrossRefPubMedGoogle Scholar
  6. 6.
    Brightman LA, Geronemus RG, Reddy KK. Laser treatment of port-wine stains. Clin Cosmet Investig Dermatol. 2015;8:27–33.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Herman-Giddens ME. Recent data on pubertal milestones in United States children: the secular trend toward earlier development. Int J Androl. 2006;29(1):241–6. ; discussion 86-90CrossRefPubMedGoogle Scholar
  8. 8.
    Herman-Giddens ME, Steffes J, Harris D, Slora E, Hussey M, Dowshen SA, et al. Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network. Pediatrics. 2012;130(5):e1058–68.CrossRefPubMedGoogle Scholar
  9. 9.
    Kaplowitz P. Update on precocious puberty: girls are showing signs of puberty earlier, but most do not require treatment. Adv Pediatr. 2011;58(1):243–58.CrossRefPubMedGoogle Scholar
  10. 10.
    Kulungowski AM, Hassanein AH, Nose V, Fishman SJ, Mulliken JB, Upton J, et al. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations. Plast Reconstr Surg. 2012;129(6):919e–24e.CrossRefPubMedGoogle Scholar
  11. 11.
    Hughes RL, Collins KA, Sullivan KE. A case of fatal iliac vein rupture associated with May-Thurner syndrome. Am J Forensic Med Pathol. 2013;34(3):222–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Wain K, Swanson K, Watson W, Jeavons E, Weaver A, Lindor N. Hereditary hemorrhagic telangiectasia and risks for adverse pregnancy outcomes. Am J Med Genet A. 2012;158A(8):2009–14.CrossRefPubMedGoogle Scholar
  13. 13.
    de Gussem EM, Lausman AY, Beder AJ, Edwards CP, Blanker MH, Terbrugge KG, et al. Outcomes of pregnancy in women with hereditary hemorrhagic telangiectasia. Obstet Gynecol. 2014;123(3):514–20.CrossRefPubMedGoogle Scholar
  14. 14.
    Berthelot E, Savale L, Guyot A, Rahmoune FC, Bouchachi A, Assayag P. Acute high output heart failure revealing hereditary hemorrhagic telangiectasia in a pregnant woman. Presse Med. 2015;44(3):362–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Yara N, Masamoto H, Iraha Y, Wakayama A, Chinen Y, Nitta H, et al. Diffuse venous malformation of the uterus in a pregnant woman with Klippel-Trenaunay syndrome diagnosed by DCE-MRI. Case Rep Obstet Gynecol. 2016;2016:4328450.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Gonzalez-Mesa E, Blasco M, Anderica J, Herrera J. Klippel-Trenaunay syndrome complicating pregnancy. BMJ Case Rep. 2012;2012Google Scholar
  17. 17.
    Gungor Gundogan T, Jacquemyn Y. Klippel-trenaunay syndrome and pregnancy. Obstet Gynecol Int. 2010;2010:706850.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Koch A, Aissi G, Gaudineau A, Sananes N, Murtada R, Favre R, et al. Klippel-Trenaunay syndrome and pregnancy: difficult choice of delivery from a case and a review of the literature. J Gynecol Obstet Biol Reprod (Paris). 2014;43(7):483–7.CrossRefGoogle Scholar
  19. 19.
    Kemfang JD, Dobgima WP, Motzebo RM, Ngassam A, Fokou M, Kasia JM. Successful management of pregnancy in an African woman with Klippel Trenaunay syndrome. Pan Afr Med J. 2013;16:99.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Atis A, Ozdemir G, Tuncer G, Cetincelik U, Goker N, Ozsoy S. Management of a Klippel-Trenaunay syndrome in pregnant women with mega-cisterna magna and splenic and vulvar varices at birth: a case report. J Obstet Gynaecol Res. 2012;38(11):1331–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Martin JR, Pels SG, Paidas M, Seli E. Assisted reproduction in a patient with Klippel-Trenaunay syndrome: management of thrombophilia and consumptive coagulopathy. J Assist Reprod Genet. 2011;28(3):217–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Rebarber A, Roman AS, Roshan D, Blei F. Obstetric management of Klippel-Trenaunay syndrome. Obstet Gynecol. 2004;104(5 Pt 2):1205–8.CrossRefPubMedGoogle Scholar
  23. 23.
    DeStephano CC, Werner EF, Holly BP, Lessne ML. Diagnosis and management of iliac vein thrombosis in pregnancy resulting from May-Thurner syndrome. J Perinatol. 2014;34(7):566–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Wax JR, Pinette MG, Rausch D, Cartin A. May-Thurner syndrome complicating pregnancy: a report of four cases. J Reprod Med. 2014;59(5–6):333–6.PubMedGoogle Scholar
  25. 25.
    Lv X, Li Y. The clinical characteristics and treatment of cerebral AVM in pregnancy. Neuroradiol J. 2015;28(4):385–8.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Seki M, Shibata M, Itoh Y, Suzuki N. Intracerebral hemorrhage due to venous thrombosis of developmental venous anomaly during pregnancy. J Stroke Cerebrovasc Dis. 2015;24(7):e185–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Boccara O, Chrétien-Marquet B, Pannier S, Guéro S, Khen-Dunlop N, Hadj-Rabia S, et al. Is surgery a triggering factor for clinical worsening of lymphatic malformations? 21st Workshop, International Society for the Study of Vascular Anomalies (ISSVA); April 26–29, 2016. Argentina: Buenos Aires; 2016.Google Scholar
  28. 28.
    Trenor 3rd CC, Chaudry G. Complex lymphatic anomalies. Semin Pediatr Surg. 2014;23(4):186–90.CrossRefPubMedGoogle Scholar
  29. 29.
    Ali S, Weiss CR, Sinha A, Eng J, Mitchell SE. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology. 2016;31(9):603–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Burrows PE. Endovascular treatment of slow-flow vascular malformations. Tech Vasc Interv Radiol. 2013;16(1):12–21.CrossRefPubMedGoogle Scholar
  31. 31.
    Qiu Y, Chen H, Lin X, Hu X, Jin Y, Ma G. Outcomes and complications of sclerotherapy for venous malformations. Vasc Endovascular Surg. 2013;47(6):454–61.CrossRefPubMedGoogle Scholar
  32. 32.
    van der Vleuten CJ, Kater A, Wijnen MH, Schultze Kool LJ, Rovers MM. Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Intervent Radiol. 2014;37(4):977–89.PubMedGoogle Scholar
  33. 33.
    Aronniemi J, Castrén E, Lappalainen K, Vuola P, Salminen P, Pitkäranta A, Pekkola J. Sclerotherapy complications of peripheral venous malformations. Phlebology. 2015. [Epub ahead of print]Google Scholar
  34. 34.
    Mohan AT, Adams S, Adams K, Hudson DA. Intralesional bleomycin injection in management of low flow vascular malformations in children. J Plast Surg Hand Surg. 2015;49(2):116–20.CrossRefPubMedGoogle Scholar
  35. 35.
    Rabe E, Pannier F. Sclerotherapy in venous malformation. Phlebology. 2013;28(Suppl 1):188–91.CrossRefPubMedGoogle Scholar
  36. 36.
    Horbach SE, Lokhorst MM, Saeed P, de Gouyon Matignon de Pontouraude CM, Rothova A, van der Horst CM. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg. 2016;69(3):295–304.CrossRefPubMedGoogle Scholar
  37. 37.
    Park SM, Bae YC, Lee JW, Kim HS, Lee IS. Outcomes of surgical treatment of vascular anomalies on the vermilion. Arch Plast Surg. 2016;43(1):19–25.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Northwell Health SystemLenox Hill HospitalNew YorkUSA

Personalised recommendations